Why Drug Companies Are Rushing to Market Ketamine Medicines
Spurred on by the Trump administration’s embrace of psychedelic medicine, researchers are experimenting with new — and not so new — forms of the anesthetic.
Read the full story at NYT Health ↗
ImpactNotable 35/100
Why it mattersRule-based estimate: no strong signals; trust 9/10.
RegionsUnited States
Published6 d ago (Tue, 20 Oct 2026 17:49:20 GMT)
RetrievedWed, 21 Oct 2026 01:00:28 GMT via rss
ClassifiedWed, 21 Oct 2026 01:00:30 GMT by heuristic
AuthorAndrew Jacobs